HOME >> BIOLOGY >> NEWS
UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders

DALLAS March 18, 2004 More than a decade of work conducted by UT Southwestern Medical Center at Dallas researchers has led to a better understanding of the underlying causes of lipodystrophies disorders characterized by the selective loss of fat tissues, resulting in metabolic complications, such as severe diabetes and high blood cholesterol levels.

By gaining a better understanding of the molecular mechanisms that lead to both inherited and acquired lipodystrophies, researchers hope to discover new therapeutic approaches to prevent the loss of fat tissues and prevent or possibly delay the onset of metabolic complications associated with these disorders.

A review article summarizing research spearheaded by scientists at UT Southwestern is published in today's issue of The New England Journal of Medicine.

"We hear about the metabolic complications of obesity all the time, but these complications also occur in disorders of fat cells that cause partial or total loss of fat from the human body the exact opposite of what occurs in obese individuals," said Dr. Abhimanyu Garg, chief of nutrition and metabolic diseases who has been studying patients with lipodystrophies for the past 16 years. "These disorders have not been widely recognized."

Recently, many HIV-infected patients being treated with a class of drugs known as protease inhibitors have developed lipodystrophies, which has raised awareness of these rare disorders.

Improved knowledge of these disorders will have implications to understanding more prevalent disorders that occur as a result of obesity, like diabetes, which affects more than 16 million Americans, Dr. Garg said.

"What we're learning from treating patients with lipodystrophies may also be applicable to obese patients with abnormal fat distribution, who are more prone to complications," Dr. Garg said. "All of these patients are predisposed to diabetes. Some of these patients even develop d
'"/>

Contact: Amy Shields
amy.shields@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
17-Mar-2004


Page: 1 2 3

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
10. UT Southwestern research halts narcolepsy symptoms
11. UT Southwestern researchers identify gene as essential for vascular smooth muscle development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... , ... CrucialTrak, a global designer and manufacturer of biometric access control systems, ... market and sell its complete line of biometric readers and access gates . ... solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be ... will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... in background and medical screening, announces the launch of a testing service ... workforce safe. The new service is provided by ClearStar’s Medical Information Services ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of ... work closely with CEO Brian Miller and Sentien’s management team. , Mr. ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString ... bringing together thousands of industry leaders, clinicians, research scientists, medical professionals and academics ... Carl June, MD, Director of the Center for Cellular Immunotherapies at the Perelman ...
(Date:5/14/2020)... ... May 13, 2020 , ... ... phenotypic readouts, providing little or no information on the drug’s mechanism of action ... characterization of compounds by measuring the activity of molecular pathways. This information can ...
Breaking Biology Technology:
Cached News: